An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.
Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Elimination
Based on TikTok, the service has removed violative content and banned related keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
After moments of entering one community, a seller shared WhatsApp details, where most transactions occur. The vendor sent an guidebook and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Item Details and Costs
Inside these communities, messages show black plastic parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.
